Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between fibronectin, proteoglycans and lipoproteins.

J Labat-Robert1, E Gruber, M Bihari-Varga

  • 1Connective Tissue Laboratory, UA CNRS 1174, Paris XII University School of Medicine, France.

International Journal of Biological Macromolecules
|February 1, 1990
PubMed
Summary

Human plasma fibronectin inhibits the formation of low-density lipoprotein (LDL) complexes with glycosaminoglycans (GAGs) and proteoglycans (PGs). This protein also dissociates pre-formed complexes, suggesting a role in preventing arterial plaque buildup.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of Joint Dental Training Programme in East of England.

British dental journal·2024
Same author

Establishment of Age-Specific Whole Blood Biochemistry and Gas Reference Intervals in Broiler Chickens using the i-STAT and the Vetscan VS2 Portable Analyzers.

Avian diseases·2022
Same author

Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity in a patient who had had a renal transplant.

The British journal of oral & maxillofacial surgery·2018
Same author

Comments on the history of medical-biological studies of aging, the birth of scientific gerontology.

Current research in translational medicine·2017
Same author

Platelets, Micro-Particles and Elastase. A Review with Extrapolation to the Mechanism of Generation and Bio-Pathology of Platelet Fragments.

Pathology oncology research : POR·2017
Same author

Longevity and aging. Mechanisms and perspectives.

Pathologie-biologie·2015

Area of Science:

  • Biochemistry
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Low-density lipoprotein (LDL) complex formation with glycosaminoglycans (GAGs) and proteoglycans (PGs) is implicated in atherosclerosis.
  • Fibronectin, a plasma protein, is found in atherosclerotic plaques and may influence disease progression.

Purpose of the Study:

  • To investigate the effect of human plasma fibronectin on the formation and dissociation of LDL-GAG and LDL-PG complexes.
  • To explore the potential physiopathological significance of fibronectin's interaction with LDL-macromolecular complexes.

Main Methods:

  • Studied the inhibition of LDL-GAG and LDL-PG complex formation by adding purified human plasma fibronectin.
  • Investigated the dissociation of pre-formed LDL-GAG and LDL-PG complexes using fibronectin.

Related Experiment Videos

  • Utilized LDL-cholesterol, GAGs, PGs, and heparin-Sepharose affinity columns in experiments.

    • Main Results:

    • Fibronectin inhibited complex formation between LDL and GAGs/PGs, even in the presence of calcium ions.
    • Fibronectin dissociated pre-formed LDL-GAG complexes (100%) and PG-LDL complexes (60%).
    • Fibronectin also dissociated LDL-heparin complexes formed on affinity columns.

    Conclusions:

    • Human plasma fibronectin inhibits LDL-GAG and LDL-PG complex formation and dissociates pre-formed complexes.
    • Fibronectin may compete more effectively at GAG binding sites on LDL compared to protein binding sites on PGs.
    • Findings suggest fibronectin's role in modulating LDL-macromolecular interactions within atherosclerotic plaques.